Literature DB >> 25465936

Impact of atrial fibrillation on outcomes in patients who underwent transcatheter aortic valve replacement.

Abhishek Maan1, E Kevin Heist1, Jonathan Passeri1, Ignacio Inglessis1, Joshua Baker1, Leon Ptaszek1, Gus Vlahakes1, Jeremy N Ruskin1, Igor Palacios1, Thoralf Sundt1, Moussa Mansour2.   

Abstract

Transcatheter aortic valve replacement (TAVR) has emerged as an alternative treatment for surgical high-risk patients with severe aortic stenosis. The aim of this study was to determine the impact of atrial fibrillation (AF) on procedural outcomes. Data from 137 patients who underwent TAVR using Edwards SAPIEN valve were reviewed. The predictors of new-onset atrial fibrillation (NOAF) after the procedure were analyzed. In addition, the post-TAVR clinical outcomes and adverse events were compared according to the presence and absence of preprocedural and postprocedural AF. Previous AF was present in 49% of the patients who underwent TAVR. After the procedure, NOAF was detected in 21% of patients, and the cumulative incidence of post-TAVR AF was 60%. After TAVR, 50% of all the episodes of NOAF occurred in the initial 24 hours after the procedure. Transapical approach was observed to an important predictor of NOAF (adjusted odds ratio [OR] 5.05, 95% confidence interval [CI] 1.40 to 18.20, p = 0.013). The composite outcome of all-cause mortality, stroke, vascular complications, and repeat hospitalization in 1 month after TAVR was significantly higher in patients with previous AF (33 of 67 vs 19 of 70, adjusted OR 2.60, 95% CI 1.22 to 5.54, p = 0.013) compared with patients who did not have previous AF. The presence of post-TAVR AF led to a prolongation in the duration of intensive care unit stay by an average of 70 hours (95% CI 25 to 114.7 hours, p = 0.002). Similarly, post-TAVR AF also led to the prolongation in the hospital stay by an average of 6.7 days (95% CI 4.69 to 8.73 days, p <0.0005). In conclusion, our study demonstrates that the presence of AF before TAVR is an important predictor of the composite end point of all-cause mortality, stroke, vascular complications, and repeat hospitalization in 1 month after the procedure. AF after TAVR is more likely to be encountered with the transapical approach and is associated with a prolongation of intensive care unit and hospital stay.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25465936     DOI: 10.1016/j.amjcard.2014.10.027

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  What Are the Predictors of Atrial Fibrillation in Coronary Artery Bypass Grafting?

Authors:  Orhan Gokalp; Levent Yilik; Hasan Iner; Gamze Gokalp
Journal:  Tex Heart Inst J       Date:  2017-02-01

2.  Incidence of arrhythmias and impact of permanent pacemaker implantation in hospitalizations with transcatheter aortic valve replacement.

Authors:  Rajkumar Doshi; Dean H Decter; Perwaiz Meraj
Journal:  Clin Cardiol       Date:  2018-05-10       Impact factor: 2.882

3.  Managing Stroke During Transcatheter Aortic Valve Replacement.

Authors:  Florian Hecker; Mani Arsalan; Thomas Walther
Journal:  Interv Cardiol       Date:  2017-05

4.  Association of Timing of Aortic Valve Replacement Surgery After Stroke With Risk of Recurrent Stroke and Mortality.

Authors:  Charlotte Andreasen; Mads Emil Jørgensen; Gunnar H Gislason; Andreas Martinsson; Robert D Sanders; Jawdat Abdulla; Per Føge Jensen; Christian Torp-Pedersen; Lars Køber; Charlotte Andersson
Journal:  JAMA Cardiol       Date:  2018-06-01       Impact factor: 14.676

5.  Transapical transcatheter aortic valve replacement in patients with or without prior coronary artery bypass graft operation.

Authors:  Konstantinos V Voudris; S Chiu Wong; Ryan Kaple; Polydoros N Kampaktsis; Andreas R de Biasi; Jonathan S Weiss; Richard Devereux; Karl Krieger; Luke Kim; Rajesh V Swaminathan; Dmitriy N Feldman; Harsimran Singh; Nikolaos J Skubas; Robert M Minutello; Geoffrey Bergman; Arash Salemi
Journal:  J Cardiothorac Surg       Date:  2016-11-29       Impact factor: 1.637

6.  Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).

Authors:  Joerg Herold; Vasiliki Herold-Vlanti; Mohammad Sherif; Blerim Luani; Christin Breyer; Klaus Bonaventura; Ruediger Braun-Dullaeus
Journal:  BMC Cardiovasc Disord       Date:  2017-12-20       Impact factor: 2.298

7.  Atrial Fibrillation Predicts Long-Term Outcome after Transcatheter Edge-to-Edge Mitral Valve Repair by MitraClip Implantation.

Authors:  Mirjam Keßler; Alexander Pott; Elnura Mammadova; Julia Seeger; Jochen Wöhrle; Wolfgang Rottbauer; Sinisa Markovic
Journal:  Biomolecules       Date:  2018-11-19

8.  Propitious temporal changes in clinical outcomes after transcatheter compared to surgical aortic valve replacement; a meta-analysis of over 65,000 patients.

Authors:  Ankur Panchal; Andreas Kyvernitakis; Geetha Rayarao; Mark Doyle; Robert W W Biederman
Journal:  J Cardiothorac Surg       Date:  2021-10-20       Impact factor: 1.637

Review 9.  Impact of new-onset versus pre-existing atrial fibrillation on outcomes after transcatheter aortic valve replacement/implantation.

Authors:  Nso Nso; Kelechi Emmanuel; Mahmoud Nassar; Rubal Bhangal; Sostanie Enoru; Adedapo Iluyomade; Jonathan D Marmur; Onyedika J Ilonze; Senthil Thambidorai; Hakeem Ayinde
Journal:  Int J Cardiol Heart Vasc       Date:  2022-01-17

10.  The development or worsening of hypertension after transcatheter aortic valve replacement (TAVR) improves short-term and long-term patient outcomes.

Authors:  Brent J Klinkhammer; Cornelius M Dyke; Thomas A Haldis
Journal:  Heart Asia       Date:  2018-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.